- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03577574
Study of Two-step Anesthesia in Posterior Vitrectomy
July 2, 2018 updated by: Aier School of Ophthalmology, Central South University
A Prospective, Randomised, Single-masked Comparison of Retrobulbar Anesthesia, Peribulbar Anesthesia and Topical Combined Subconjunctival(Two-step) Anesthesia in Posterior Vitrectomy
A prospective, randomised, single-masked comparison of local anaesthetic approaches including topical anesthesia combined sub-conjunctival anesthesia(two-step anesthesia) for minimally invasive vitrectomy(TAMIV)vs peribulbar block vs retrobulbar block
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Detailed Description
Purpose: topical anesthesia combined sub-conjunctival anesthesia(two-step anesthesia) for minimally invasive vitrectomy Methods: This prospective, randomized, single-blinded clinical trail is conducted at Shanghai Aier Eye Hospital.
Selected group of 60 patients with retinal-vitreous diseases will be randomized divided into 3 groups and underwent 25-gauge vitrectomy.
Group1 uses two-step anesthesia , whereas Group 2 uses retrobulbar anesthesia, group 3 uses peribulbar anesthesia.
A 5-point Visual Analogue Pain Scale is used to assess patients' pain score and surgeon's ease while operating.
Any complications therefore will be made note of.
Study Type
Interventional
Enrollment (Anticipated)
90
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Hua Fan
- Phone Number: +8618988761617
- Email: fanhua1116@163.com
Study Locations
-
-
-
Shanghai, China
- Recruiting
- Wensheng Li
-
Contact:
- Hua Fan
- Phone Number: +8618988761617
- Email: fanhua1116@163.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
28 years to 83 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Proliferative diabetic retinopathy (PDR);
- Vitreous haemorrhage (VH);
- Retinal detachment (RD);
- Retinal vein occlusion(RVO);
- Other diseases (idiopathic macular hole, macular pucker and high myopic maculopathy);
- Silicone oil-filled eye.
Exclusion Criteria:
- Communication problems;
- Allergy to amide-type local anaesthetic agents;
- History of vitreoretinal surgery or orbital surgery;
- Orbital deformity;
- With episcleral adjunct surgery;
- Trauma;
- Keratitis;
- Conjunctivitis and active uveitis.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: retrobulbar anesthesia group
2% lidocaine 4ml injected into retrobulbar space
|
2% lidocaine 4ml injected into retrobulbar space
|
Active Comparator: peribulbar anesthesia group
2% lidocaine 4 to 8ml injected into peribulbar space
|
2% lidocaine 4 to 8ml injected into peribulbar space
|
Experimental: two step anesthesia group
conjunctival cul-de-sac anesthetized with 0.5% proparacaine hydrochloride drops three times + 2% lidocaine 0.6 to 0.8ml subconjunctival injection
|
conjunctival cul-de-sac anesthetized with 0.5% proparacaine hydrochloride drops three times + 2% lidocaine 0.6 to 0.8ml subconjunctival injection
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
pain scores
Time Frame: During surgery
|
5-point Visual Analogue Pain Scale(VAPS): Grade 1: No pain or discomfort; Grade 2: mild pain or discomfort; Grade 3: moderate pain or discomfort; Grade 4: severe pain or discomfort;
|
During surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
surgeon's ease
Time Frame: During surgery
|
Grade 1: No discomfort; Grade 2: mild discomfort; Grade 3: moderate discomfort; Grade 4: severe discomfort;
|
During surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Wensheng Li, Shanghai Aier Eye Hosptial
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Chan WM, Loo AV, Tam BS. Topical anesthesia in posterior vitrectomy. Retina. 2000;20(5):563-5. doi: 10.1097/00006982-200005000-00029. No abstract available.
- Bahcecioglu H, Unal M, Artunay O, Rasier R, Sarici A. Posterior vitrectomy under topical anesthesia. Can J Ophthalmol. 2007 Apr;42(2):272-7.
- Schrader WF, Schargus M, Schneider E, Josifova T. Risks and sequelae of scleral perforation during peribulbar or retrobulbar anesthesia. J Cataract Refract Surg. 2010 Jun;36(6):885-9. doi: 10.1016/j.jcrs.2009.12.029.
- Takaschima A, Marchioro P, Sakae TM, Porporatti AL, Mezzomo LA, De Luca Canto G. Risk of Hemorrhage during Needle-Based Ophthalmic Regional Anesthesia in Patients Taking Antithrombotics: A Systematic Review. PLoS One. 2016 Jan 22;11(1):e0147227. doi: 10.1371/journal.pone.0147227. eCollection 2016.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
August 2, 2018
Primary Completion (Anticipated)
January 1, 2019
Study Completion (Anticipated)
January 1, 2019
Study Registration Dates
First Submitted
May 28, 2018
First Submitted That Met QC Criteria
July 2, 2018
First Posted (Actual)
July 5, 2018
Study Record Updates
Last Update Posted (Actual)
July 5, 2018
Last Update Submitted That Met QC Criteria
July 2, 2018
Last Verified
May 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- SHIRB2018013
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Anesthesia, Local
-
Grünenthal GmbHTerminatedAnalgesia | Anesthesia, Local | AnesthesiaNetherlands
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMNot yet recruitingPrediction Models for Cardiovascular and Neurocognitive Disease Risk in the General Population (CME)Anesthesia, Local | AnesthesiaFrance
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | AnesthesiaGermany
-
Charite University, Berlin, GermanyCompletedAnesthesia, Local | Anesthesia | Anesthesia; Adverse EffectGermany
-
Assistance Publique - Hôpitaux de ParisINSERM UMR-942, Paris, France; M3DISIMRecruiting
-
Novocol Pharmaceutical of Canada, Inc.CompletedAnesthesia, Local | Dental Anesthesia | Anesthesia, ReversalUnited States
-
University Health Network, TorontoRecruiting
-
Kfir SiagNot yet recruiting
-
Hams Hamed AbdelrahmanCompleted
-
University of BaghdadActive, not recruiting
Clinical Trials on retrobulbar anesthesia
-
Yonsei UniversityTerminated
-
Yonsei UniversityUnknown
-
Aier School of Ophthalmology, Central South UniversityUnknownRetinitis Pigmentosa
-
Oregon Health and Science UniversityNational Eye Institute (NEI); National Institutes of Health (NIH)Terminated
-
Oregon Health and Science UniversityNational Eye Institute (NEI); National Institutes of Health (NIH)WithdrawnSTROMAL OPACITIES
-
Wenzhou Medical UniversityUnknownCorneal Opacity | Corneal Dystrophies, Hereditary | Keratitis, Herpetic | Corneal UlcerChina
-
MD Stem CellsRecruitingGlaucoma | Age-Related Macular Degeneration | Macular Degeneration | Retinitis Pigmentosa | Leber Hereditary Optic Neuropathy | Optic Atrophy | Blindness | Optic Neuropathy | Vision, Low | Retinal Disease | Stargardt Disease | Maculopathy | Retinopathy | Optic Nerve Disease | Nonarteritic Ischemic Optic Neuropathy | Vision... and other conditionsUnited States, United Arab Emirates
-
MD Stem CellsUnknownGlaucoma | Macular Degeneration | Retinal Disease | Hereditary Retinal Dystrophy | Optic Nerve DiseaseUnited States
-
Queen's UniversityCompleted
-
Penn State UniversityTerminatedIntraoperative Floppy Iris SyndromeUnited States